Bolus-tracking MRI with a simultaneous T1- and T*2-measurement

Magnetic Resonance in Medicine

Volumn 62, Issue 3, 2009, Pages 672-681

  Sourbron, S ^a   Heilmann, M ^b,c   Biffar, A ^a   Walczak, C ^b,c   Vautier, J ^b,c   Volk, A ^b,c   Peller, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUT CURIE   (France)

^c Centre Universitaire   (France)

Author keywords

Dynamic contrast enhanced; Dynamic susceptibility contrast; Perfusion; Permeability; Relaxivity

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; MAMMALS; MECHANICAL PERMEABILITY; TISSUE;

COLORECTAL TUMORS; DYNAMIC CONTRAST ENHANCED; DYNAMIC CONTRAST ENHANCED MRIS (DCE); DYNAMIC SUSCEPTIBILITY CONTRAST; GENERALIZED MODELS; PERFUSION; RELAXIVITY; SUSCEPTIBILITY LOSS;

TRACERS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CLINICAL EVALUATION; COLORECTAL TUMOR; CONTROLLED STUDY; EXTRAVASCULAR SPACE; GEOMETRY; HUMAN; IMAGE QUALITY; INTESTINE TRANSIT TIME; INTRAVASCULAR SPACE; KINETICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TISSUE STRUCTURE;

EID: 69449091291     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22042     Document Type: Article

References (40)

1. Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RL, Buxton RB, Chao Y-S, Wedeen VJ, Brady TJ. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174.
2. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;6:249-265.
3. Sorensen AG, Reimer P. Cerebral MR perfusion imaging. Stuttgart: Georg Thieme Verlag, 2000.
4. Delille JP, Slanetz PJ, Yeh ED, Kopand DB, Garrido L. Breast cancer: Regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging - initial results. Radiology 2002;223:558-565. (Pubitemid 34454343)
5. Aumann S, Schoenberg SO, Just A, Briley-Saebo K, Bjørnerud A, Bock M M, Brix G. Quantification of renal perfusion using an intravascular contrast agent. I. Results in a canine model. Magn Reson Med 2003;49:276-287.
6. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, Griebel J. Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420-429. (Pubitemid 39025290)
7. Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall BE, Kingsley DP, Mosely IF, du Boulay EP, McDonald WI. Heterogeneity of blood-brain barrier changes in multiple sclerosis: An MRI study with gadolinium-dtpa enhancement. Neurology 1990;40:229-235.
8. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131. (Pubitemid 20353802)
9. Wirestam R, Knuttson L, Risberg J, Börjesson S, Larsson EM, Gustafson L, Passant U, Ståhlberg F. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imagng: A simplified t1-weighted steady-state cerebral blood volume approach. Acta Radiol 2007;48:550-556. (Pubitemid 46801827)
10. Kiselev VG. Transverse relaxation effect of MRI contrast agents: A crucial issue for quantitative measurements of cerebral perfusion. J Magn Reson Imaging 2005;22:693-696.
11. Kjølby BF, Østergaard L, Kiselev VG. Theoretical model of intravascular paramagnetic tracers effect on tissue relaxation. Magn Reson Med 2006;56:187-197.
12. Newman GC, Hospod FE, Patlak CS, Fain SE, Pulfer KA, Cook TD, O'Sullivan F. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI. J Cereb Blood Flow Metab 2006;26:760-770.
13. 99mTc-RBC SPECT. J Neurosurg Anesthesiol 2008;20:41-44.
14. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol 2006;27:859-867.
15. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR Imaging. Radiology 2002;223:11-29. (Pubitemid 34258186)
16. Quarles CC, Ward BD, Schmainda KM. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005;53:1307-1316.
17. Uematsu H, Maeda M, Sadato N, Matsuda T, Ishimori Y, Koshimoto Y, Yamada H, Kimura H, Kawamura Y, Matsuda T, Hayashi N, Yonekura Y, Ishii Y. Vascular permeability: Quantitative measurement with double-echo dynamic MR imaging - Theory and clinical application. Radiology 2000;214:912-917. (Pubitemid 30115402)
18. 1-changes in tissue and correction for intravascular water exchange. Magn Reson Med 2006;56:138-145.
19. Heilmann M, Walczak C, Vautier J, Dimicoli J-L, Thomas CD, Lupu M, Mispelter J, Volk A. Simultaneous dynamic T1 and T2* measurement for AIF assessment combined with DCE MRI in a mouse tumor model. Magn Reson Mater Phys 2007;20:193-203. (Pubitemid 350132158)
20. Lassen NA, Perl WP. Tracer kinetic methods in medical physiology. New York: Raven Press; 1979.
21. Larsson HBW, Rosenbaum S, Fritz-Hansen T. Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart. Magn Reson Med 2001;46:272-281. (Pubitemid 32703272)
22. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann K-P, Claussen CD, Schick F. Relaxivity of gadopentetate dimeglumine (magnevist), gadobutrol (gadovist) and gadobenate dimeglumine (multihance) in human blood plasma at 0.2, 1.5 and 3 tesla. Invest Radiol 2006;41:213-221. (Pubitemid 44406181)
23. Fritz-Hansen T, Rostrup E, Larsson HB, Søndergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: A step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-231. (Pubitemid 26271742)
24. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994;32:66-76. (Pubitemid 24198557)
25. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724. (Pubitemid 41546838)
26. Heilmann M, Dimicoli JL, Thomas CD, Walczak C, Volk A. Contrast agent distribution function (CADF), a new dynamic MRI parameter from simultaneous measurement of relaxation rates R1 and R2* by a new saturation-recovery multi-gradient-echo snapshot sequence: Concept and first application to colorectal tumor xenografts in mice. Proc Intl Soc Magn Reson Med 2006;14:2906.
27. Sourbron S, Michaely HJ, Reiser MF, Schoenberg SO. MRI-measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model. Invest Radiol 2008;43:40-48.
28. Rempp KA, Brix G, Wenz F, Becker C, Gückel C, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641. (Pubitemid 24366927)
29. Johnson KM, Tao JZ, Kennan RP, Gore JC. Intravascular susceptibility agent effects on tissue transverse relaxation rates in vivo. Magn Reson Med 2000;44:909-914.
30. Heilmann M, Sourbron S, Walczak C, Biffar A, Vautier J, Peller M, Volk A. Combination of DCE and DSC MRI: Added value in the study of tumor vascularization. Proc Intl Soc Magn Reson Med 2008;18:446.
31. Johnson G, Wetzel SG, Cha S, Babb J, Tofts PS. Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI. Magn Reson Med 2004;51:961-968.
32. Law M, Young R, Babb J, Rad M, Sasaki T, Zagzag D, Johnson G. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 2006;27:1975-1982. (Pubitemid 44556520)
33. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, Ovbiagele B, Kim D, Ali LK, Sanossian N, Jahan R, Duckwiler GR, Vinuela F, Salamon N, Villablanca JP, Liebeskind DS. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol 2007;62:170-176. (Pubitemid 47546502)
34. Calamante F, Vonken E-JPA, van Osch MJP. Contrast agent concentration measurements affecting quantification of bolus-tracking perfusion MRI. Magn Reson Med 2007;58:544-553. (Pubitemid 350154965)
35. Landis CS, Li X, Telang FW, Molina PE, Palyka I, Vetek G, Springer CS Jr. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn Reson Med 1999;42:467-478. (Pubitemid 29416208)
36. Buckley DL. Transcytolemmal water exchange and its effect on the determination of contrast agent concentration in vivo. Magn Reson Med 2002;47:420-421.
37. Buckley DL, Kershaw LE, Stanisz G. Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: Dynamic contrast-enhanced MRI of human internal obturator muscle. Magn Reson Med 2008;60:1011-1019.
38. Larsson HB, Hansen AE, Berg HK, Rostrup E, Haraldseth O. Dynamic contrast-enhanced quantitative perfusion measurement of the brain using T1-weighted MRI at 3T. J Magn Reson Imaging 2008;27:754-762.
39. Jacquez JA. Compartmental analysis in biology and medicine. USA: The University of Michigan Press; 1985.
40. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.